NASDAQ:LUMO

Lumos Pharma News Headlines

$11.97
+0.08 (+0.67 %)
(As of 04/15/2021 12:55 PM ET)
Add
Compare
Today's Range
$11.97
Now: $11.97
$11.97
50-Day Range
$10.90
MA: $12.94
$14.97
52-Week Range
$7.62
Now: $11.97
$36.72
Volume200 shs
Average Volume60,722 shs
Market Capitalization$99.73 million
P/E RatioN/A
Dividend YieldN/A
Beta1.69

Headlines

Lumos Pharma (NASDAQ LUMO) News Headlines Today

SourceHeadline
Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone DeficiencyLumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
finance.yahoo.com - April 14 at 6:03 PM
Lumos Pharma (NASDAQ:LUMO) Coverage Initiated at JonestradingLumos Pharma (NASDAQ:LUMO) Coverage Initiated at Jonestrading
americanbankingnews.com - April 13 at 8:48 AM
Reviewing Lumos Pharma (NASDAQ:LUMO) and Relmada Therapeutics (NASDAQ:RLMD)Reviewing Lumos Pharma (NASDAQ:LUMO) and Relmada Therapeutics (NASDAQ:RLMD)
americanbankingnews.com - April 5 at 2:14 PM
-$0.85 Earnings Per Share Expected for Lumos Pharma, Inc. (NASDAQ:LUMO) This Quarter-$0.85 Earnings Per Share Expected for Lumos Pharma, Inc. (NASDAQ:LUMO) This Quarter
americanbankingnews.com - April 3 at 8:20 AM
Lumos Pharma Stock Is Estimated To Be Significantly OvervaluedLumos Pharma Stock Is Estimated To Be Significantly Overvalued
finance.yahoo.com - March 31 at 9:15 AM
Looking In On Lumos PharmaLooking In On Lumos Pharma
seekingalpha.com - March 29 at 7:10 AM
Lumos Pharma Inc.Lumos Pharma Inc.
barrons.com - March 23 at 6:57 PM
Data Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201’s Potential as a Therapeutic for Pediatric Growth Hormone DeficiencyData Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201’s Potential as a Therapeutic for Pediatric Growth Hormone Deficiency
finance.yahoo.com - March 20 at 12:24 PM
Lumos Pharma to Participate in March 2021 Investor ConferencesLumos Pharma to Participate in March 2021 Investor Conferences
finance.yahoo.com - March 11 at 7:53 PM
Lumos Pharmas (LUMO) CEO Rick Hawkins on Q4 2020 Results - Earnings Call TranscriptLumos Pharma's (LUMO) CEO Rick Hawkins on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 11 at 2:52 PM
Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHDLumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
finance.yahoo.com - March 9 at 5:10 PM
Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine SocietyData Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
finance.yahoo.com - March 4 at 10:07 AM
Lumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual MeetingLumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual Meeting
finance.yahoo.com - March 2 at 7:00 PM
Will Lumos Pharma (LUMO) Report Negative Earnings Next Week? What You Should KnowWill Lumos Pharma (LUMO) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - March 2 at 1:59 PM
Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021
finance.yahoo.com - February 22 at 6:34 PM
Lumos Pharma Announces Changes to its Board of DirectorsLumos Pharma Announces Changes to its Board of Directors
finance.yahoo.com - February 16 at 8:19 PM
Lumos Pharma (LUMO) in Focus: Stock Moves 8.3% HigherLumos Pharma (LUMO) in Focus: Stock Moves 8.3% Higher
nasdaq.com - December 18 at 12:02 PM
Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 ConferenceLumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 Conference
finance.yahoo.com - December 18 at 12:02 PM
What You Need To Know About Lumos Pharma, Inc.s (NASDAQ:LUMO) Investor CompositionWhat You Need To Know About Lumos Pharma, Inc.'s (NASDAQ:LUMO) Investor Composition
finance.yahoo.com - December 16 at 11:47 AM
Is Lumos Pharma (LUMO) A Good Stock To Buy Now?Is Lumos Pharma (LUMO) A Good Stock To Buy Now?
finance.yahoo.com - November 30 at 6:07 PM
Lumos Pharma to Participate in December Investor ConferencesLumos Pharma to Participate in December Investor Conferences
finance.yahoo.com - November 23 at 10:22 PM
Lumos Pharma, Inc. (LUMO) CEO Rick Hawkins on Q3 2020 Results - Earnings Call TranscriptLumos Pharma, Inc. (LUMO) CEO Rick Hawkins on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 9:33 AM
Lumos Pharma EPS beats by $0.86, misses on revenueLumos Pharma EPS beats by $0.86, misses on revenue
seekingalpha.com - November 10 at 7:18 PM
Lumos Pharma Inc to Host Earnings CallLumos Pharma Inc to Host Earnings Call
finance.yahoo.com - November 10 at 7:18 PM
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial ResultsLumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 10 at 7:18 PM
Lumos Pharma (LUMO) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseLumos Pharma (LUMO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - November 3 at 5:13 PM
Lumos Pharma to Participate in November Investor ConferencesLumos Pharma to Participate in November Investor Conferences
finance.yahoo.com - October 29 at 9:24 AM
Lumos Pharma to Report Third Quarter 2020 Financial Results and Host a Conference Call on November 10, 2020Lumos Pharma to Report Third Quarter 2020 Financial Results and Host a Conference Call on November 10, 2020
finance.yahoo.com - October 27 at 5:04 PM
Lumos Pharma to Participate in Upcoming Investor ConferencesLumos Pharma to Participate in Upcoming Investor Conferences
feeds.benzinga.com - August 27 at 9:35 AM
Lumos Pharma, Inc. 2020 Q2 - Results - Earnings Call PresentationLumos Pharma, Inc. 2020 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 14 at 1:21 PM
Lumos Pharma, Inc. (LUMO) CEO Rick Hawkins on Q2 2020 Results - Earnings Call TranscriptLumos Pharma, Inc. (LUMO) CEO Rick Hawkins on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 13 at 10:41 PM
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate ActivitiesLumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
finance.yahoo.com - August 13 at 5:40 PM
Lumos Pharma, Inc. Common Stock (LUMO)Lumos Pharma, Inc. Common Stock (LUMO)
nasdaq.com - August 10 at 8:52 PM
Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020
finance.yahoo.com - July 28 at 5:55 PM
Lumos Pharma Announces Sale of Priority Review VoucherLumos Pharma Announces Sale of Priority Review Voucher
finance.yahoo.com - July 27 at 6:07 PM
Is Lumos Pharma (NASDAQ:LUMO) In A Good Position To Deliver On Growth Plans?Is Lumos Pharma (NASDAQ:LUMO) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - June 19 at 1:11 PM
Is Lumos Pharma, Inc. (LUMO) A Good Stock To Buy?Is Lumos Pharma, Inc. (LUMO) A Good Stock To Buy?
finance.yahoo.com - June 10 at 6:03 PM
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate ActivitiesLumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
finance.yahoo.com - May 28 at 7:53 PM
Lumos Pharma to Participate in the Jefferies 2020 Healthcare ConferenceLumos Pharma to Participate in the Jefferies 2020 Healthcare Conference
finance.yahoo.com - May 27 at 6:11 PM
Lumos Pharma to Report First Quarter 2020 Financial Results and Host a Conference Call on May 28, 2020Lumos Pharma to Report First Quarter 2020 Financial Results and Host a Conference Call on May 28, 2020
finance.yahoo.com - May 26 at 2:28 PM
Lumos Pharma Hires Biotech Veteran Aaron Schuchart as Chief Business OfficerLumos Pharma Hires Biotech Veteran Aaron Schuchart as Chief Business Officer
finance.yahoo.com - May 1 at 5:57 PM
This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.